You just read:

Lin Bioscience Licenses First-in-Class Therapeutic Program to treat Dry Aged-Related Macular Degeneration from Columbia University in Collaboration with NIH

News provided by

Lin Bioscience Inc.

Jan 06, 2017, 08:00 ET